The Scientist

» drug development and microbiology

Most Recent

image: FDA Calls for Data on ALS Drug

FDA Calls for Data on ALS Drug

By | April 21, 2015

In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.

1 Comment

image: How a Popular Probiotic Works

How a Popular Probiotic Works

By | April 16, 2015

Eating a type of bacterium encourages the activity of other gut microbes, according to a small study.

0 Comments

image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.

2 Comments

image: Enzyme Improves CRISPR

Enzyme Improves CRISPR

By | April 1, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

0 Comments

image: Manipulative Microbiomes

Manipulative Microbiomes

By | April 1, 2015

Gut bacteria control tumor growth via the mammalian immune system.

3 Comments

image: Soil Bacteria Live on Wine Grapes

Soil Bacteria Live on Wine Grapes

By | March 25, 2015

The earthiness of Merlot may have to do with grapevine-dwelling microbiota.

2 Comments

image: Quorum-Sensing Molecule Modifies Gut Microbiota

Quorum-Sensing Molecule Modifies Gut Microbiota

By | March 19, 2015

Increasing the abundance of a chemical some microbes use to communicate with one another can help reinstate beneficial bacterial populations in the guts of antibiotic-treated mice. 

1 Comment

image: 23andMe Enters Drug Development

23andMe Enters Drug Development

By | March 12, 2015

The personal genomics firm announces plans to make medicines.

4 Comments

image: Sewage Bacteria Linked to Obesity

Sewage Bacteria Linked to Obesity

By | March 10, 2015

Microbes identified in a city’s sewage treatment plants correlate with the population’s obesity rate, a study shows.

1 Comment

image: AbbVie Wins Bidding War for Cancer Drugmaker

AbbVie Wins Bidding War for Cancer Drugmaker

By | March 5, 2015

The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.

0 Comments

Popular Now

  1. Next Generation: Nanotube Scaffolds Reconnect Spinal Neurons
  2. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  3. Stroke Alters Gut Microbiome, Impacting Recovery
  4. Your Office Has a Distinct Microbiome
RayBiotech